Back to User profile » Dr Emanuela Mazzon
Papers published by Dr Emanuela Mazzon:
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
Gugliandolo A, Longo F, Marrosu MG, Mancardi GL, Gandoglia I, Melis M, Lo Giudice F, Bramanti P, Mazzon E
Therapeutics and Clinical Risk Management 2018, 14:1765-1788
Published Date: 26 September 2018
A novel role in skeletal segment regeneration of extracellular vesicles released from periodontal-ligament stem cells
Diomede F, D'Aurora M, Gugliandolo A, Merciaro I, Ettorre V, Bramanti A, Piattelli A, Gatta V, Mazzon E, Fontana A, Trubiani O
International Journal of Nanomedicine 2018, 13:3805-3825
Published Date: 29 June 2018
Comparison of efficacy and safety of oral agents for the treatment of relapsing–remitting multiple sclerosis
Guarnera C, Bramanti P, Mazzon E
Drug Design, Development and Therapy 2017, 11:2193-2207
Published Date: 28 July 2017
Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis
Guarnera C, Bramanti P, Mazzon E
Therapeutics and Clinical Risk Management 2017, 13:871-879
Published Date: 14 July 2017
Moringin activates Wnt canonical pathway by inhibiting GSK3β in a mouse model of experimental autoimmune encephalomyelitis
Giacoppo S, Soundara Rajan T, De Nicola GR, Iori R, Bramanti P, Mazzon E
Drug Design, Development and Therapy 2016, 10:3291-3304
Published Date: 4 October 2016